BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16391714)

  • 1. Age-related alterations in cyclic nucleotide phosphodiesterase activity in dystrophic mouse leg muscle.
    Bloom TJ
    Can J Physiol Pharmacol; 2005 Nov; 83(11):1055-60. PubMed ID: 16391714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic nucleotide phosphodiesterase isozymes expressed in mouse skeletal muscle.
    Bloom TJ
    Can J Physiol Pharmacol; 2002 Dec; 80(12):1132-5. PubMed ID: 12564638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
    de Vente J; Markerink-van Ittersum M; Vles JS
    J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in cyclic nucleotide phosphodiesterase activity and calmodulin concentration in heart muscle of cardiomyopathic hamsters.
    Masunaga R; Nagasaka A; Sawai Y; Hayakawa N; Nakai A; Hotta K; Kato Y; Hishida H; Takahashi H; Naka M; Shimada Y; Tanaka T; Hidaka H; Itoh M
    J Mol Cell Cardiol; 2004 Sep; 37(3):767-74. PubMed ID: 15350849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of an in vivo hormonally regulated phosphodiesterase 3 (PDE3) associated with a liver Golgi-endosomal fraction.
    Geoffroy V; Fouque F; Lugnier C; Desbuquois B; Benelli C
    Arch Biochem Biophys; 2001 Mar; 387(1):154-62. PubMed ID: 11368177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of renal ecto-phosphodiesterase.
    Jackson EK; Ren J; Zacharia LC; Mi Z
    J Pharmacol Exp Ther; 2007 May; 321(2):810-5. PubMed ID: 17308037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma membrane-bound cyclic AMP phosphodiesterase activity in 3T3-L1 adipocytes.
    Zhang X; Carey GB
    Comp Biochem Physiol B Biochem Mol Biol; 2004 Mar; 137(3):309-16. PubMed ID: 15050518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of phosphodiesterase activity, airway inflammation and hyperresponsiveness by PDE4 inhibitor and glucocorticoid in a murine model of allergic asthma.
    Sun JG; Deng YM; Wu X; Tang HF; Deng JF; Chen JQ; Yang SY; Xie QM
    Life Sci; 2006 Oct; 79(22):2077-85. PubMed ID: 16875702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cyclic nucleotide phosphodiesterase 3A in isolated rat submandibular acini.
    Shimizu K; Murata T; Hiramoto K; Sugiyama T; Nakagawa T; Manganiello VC; Tagawa T
    Arch Oral Biol; 2006 Feb; 51(2):83-8. PubMed ID: 16102722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. l-Glutamine administration reduces oxidized glutathione and MAP kinase signaling in dystrophic muscle of mdx mice.
    Mok E; Constantin B; Favreau F; Neveux N; Magaud C; Delwail A; Hankard R
    Pediatr Res; 2008 Mar; 63(3):268-73. PubMed ID: 18287965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
    Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY
    Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of increased cAMP content on inflammation, oxidative stress and PDE4 transcripts during Brucella melitensis infection.
    Erdogan S; Aslantas O; Celik S; Atik E
    Res Vet Sci; 2008 Feb; 84(1):18-25. PubMed ID: 17397885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the cAMP-phosphodiesterase PDE4D isoforms and age-related changes in follicle-stimulating hormone-stimulated PDE4 activities in immature rat sertoli cells.
    Levallet G; Levallet J; Bouraïma-Lelong H; Bonnamy PJ
    Biol Reprod; 2007 May; 76(5):794-803. PubMed ID: 17215491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of cyclic nucleotide phosphodiesterases in granulocytes of chronic myelogenous leukemia (CML). A preliminary report.
    Naskalski JW; Uciński WS
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):134-40. PubMed ID: 2581858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterase 4 inhibition reduces skeletal muscle atrophy.
    Hinkle RT; Dolan E; Cody DB; Bauer MB; Isfort RJ
    Muscle Nerve; 2005 Dec; 32(6):775-81. PubMed ID: 16116651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K
    Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive nuclear factor-kappaB activation resistant to inhibition by contraction and curcumin in mdx mice.
    Durham WJ; Arbogast S; Gerken E; Li YP; Reid MB
    Muscle Nerve; 2006 Sep; 34(3):298-303. PubMed ID: 16718687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of cyclic AMP phosphodiesterase activity of several subcellular fractions of rat brain after pretreatment with phospholipase C.
    Azila N; Kuppusamy UR; Ong KK
    Biochem Int; 1989 Nov; 19(5):1077-85. PubMed ID: 2561441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time monitoring of phosphodiesterase inhibition in intact cells.
    Herget S; Lohse MJ; Nikolaev VO
    Cell Signal; 2008 Aug; 20(8):1423-31. PubMed ID: 18467075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cAMP and cGMP-phosphodiesterase isoenzymes 3, 4, and 5 in the human clitoris: immunohistochemical and molecular biology study.
    Oelke M; Hedlund P; Albrecht K; Ellinghaus P; Stief CG; Jonas U; Andersson KE; Uckert S
    Urology; 2006 May; 67(5):1111-6. PubMed ID: 16635522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.